Page last updated: 2024-10-22

amifostine anhydrous and Deficiency, Magnesium

amifostine anhydrous has been researched along with Deficiency, Magnesium in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research Excerpts

ExcerptRelevanceReference
"Cisplatin is not directly toxic to bone, but cisplatin nephrotoxicity leading to magnesium wasting may affect magnesium and calcium metabolism, both of which contribute to bone integrity."2.42Cisplatin nephrotoxicity affects magnesium and calcium metabolism. ( Goren, MP, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goren, MP1

Reviews

1 review available for amifostine anhydrous and Deficiency, Magnesium

ArticleYear
Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
    Medical and pediatric oncology, 2003, Volume: 41, Issue:3

    Topics: Adult; Amifostine; Antineoplastic Agents; Calcium; Child; Cisplatin; Clinical Trials as Topic; Human

2003